Tardiff, B.E.

patient ck-mb trial event elevation investigator infarction site investigators 6- month mortality mortality level end-point enzyme pursuit ratio peak ck-mb ratios study month intervention treatment syndrome ck-mb elevation pursuit trial table result periprocedural necrosis site investigator category percutaneou enrolment committee adjudication group ck-mb levels enzyme elevations death heart outcome assessment peak ck-mb ratio events committee america analysis event rates disagreement angina definition glycoprotein criteria review effect 6 months creatine mahaffey europe peak ck-mb level process adjudicated eptifibatide prognostic implications califf rm /iiia <0.001 circulation physician peak ck-mb categories model end-point mi prognostic cardiol peak creatine kinase cec process limit 30 days regression model peak ck-mb levels platelet treatment effect topol ej